Richard Holland, Eagle's CBO, will be travelling again spreading the word about Eagle Genomics and keeping up with the latest developments in the technology and best practices in our field. This time he will be attending NGS For Drug Developers on 31st July - 2nd August in the great city of Boston.
This conference will address the key question about what to do with sequencing data: how to convert the experimental data into biomarkers, drug targets and other critical information. As you know, it is so much cheaper and quicker to generate data than couple of years ago while the cost of analysing these data becomes relatively more expensive.
To see more about the conference please go here.